These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 9285256

  • 1. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.
    Böhm V, Tiroke K, Schneider S, Sperschneider H, Stein G, Bitsch R.
    Int J Vitam Nutr Res; 1997; 67(4):262-6. PubMed ID: 9285256
    [Abstract] [Full Text] [Related]

  • 2. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 3. Assessment of thiamin status in chronic renal failure patients, transplant recipients and hemodialysis patients receiving a multivitamin supplementation.
    Frank T, Czeche K, Bitsch R, Stein G.
    Int J Vitam Nutr Res; 2000 Jul; 70(4):159-66. PubMed ID: 10989764
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5. Oxalic Acid as a uremic toxin.
    Mydlík M, Derzsiová K.
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [Abstract] [Full Text] [Related]

  • 6. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients.
    Fumeron C, Nguyen-Khoa T, Saltiel C, Kebede M, Buisson C, Drüeke TB, Lacour B, Massy ZA.
    Nephrol Dial Transplant; 2005 Sep; 20(9):1874-9. PubMed ID: 15972322
    [Abstract] [Full Text] [Related]

  • 7. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C, Petrarulo M, Massarenti P, Berutti S, Fenoglio R, Pauletto D, Lanfranco G, Bergamo D, Sandri L, Marangella M.
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [Abstract] [Full Text] [Related]

  • 8. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A, Gader AM, Huraib S, Mitwalli A, Al-Suleimani F, Al-Wakeel J.
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [Abstract] [Full Text] [Related]

  • 9. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
    Washio K, Inagaki M, Tsuji M, Morio Y, Akiyama S, Gotoh H, Gotoh T, Gotoh Y, Oguchi K.
    Nephron Clin Pract; 2008 Jun; 109(2):c49-54. PubMed ID: 18544955
    [Abstract] [Full Text] [Related]

  • 10. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.
    Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, Mischak H, Drüeke TB, Lacour B, Massy ZA.
    Proteomics; 2006 Feb; 6(3):993-1000. PubMed ID: 16372263
    [Abstract] [Full Text] [Related]

  • 11. [Levels of serum ascorbate and its metabolites in hemodialysis patients].
    Hirano H, Tone Y, Otani H, Oya M, Kimura K, Saika Y, Fujii R, Mune M, Ichinose M, Yukawa S.
    Nihon Jinzo Gakkai Shi; 2004 Jul; 46(5):426-33. PubMed ID: 15446598
    [Abstract] [Full Text] [Related]

  • 12. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 13. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
    Sebeková K, Podracká L, Heidland A, Schinzel R.
    Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
    [Abstract] [Full Text] [Related]

  • 14. The effect of a keto acid supplement on the course of chronic renal failure and nutritional parameters in predialysis patients and patients on regular hemodialysis therapy: the Hungarian Ketosteril Cohort Study.
    Zakar G, Hungarian Ketosteril Cohort Study.
    Wien Klin Wochenschr; 2001 Sep 17; 113(17-18):688-94. PubMed ID: 11603104
    [Abstract] [Full Text] [Related]

  • 15. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
    Fellah H, Feki M, Souissi M, Ghorbel H, Ben Abdallah T, Massy Z, Hedhili A, Ben Maiz H, Lacour B, Kaabachi N, Mebazaa A.
    Tunis Med; 2006 Nov 17; 84(11):724-9. PubMed ID: 17294900
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients.
    Ono K.
    Clin Nephrol; 1989 Jan 17; 31(1):31-4. PubMed ID: 2914408
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
    Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C.
    J Ren Nutr; 2002 Jul 17; 12(3):183-9. PubMed ID: 12105816
    [Abstract] [Full Text] [Related]

  • 20. [Plasma zinc content in patients with chronic renal insufficiency before and after kidney transplantation].
    Babarykin DA, Shul'man OM, Berzin' NI, Chernevskis KhK.
    Ter Arkh; 1985 Jul 17; 57(6):101-3. PubMed ID: 3906986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.